Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022
Operating activities
Net income	$ 934	$ 1,062
Adjustments to reconcile net income to operating cash flows:
Depreciation and amortization	338	351
Postretirement benefit plan expense (benefit)	(105)	(189)
Deferred income taxes	0	26
Stock compensation	62	56
Loss on Russia divestiture	113	0
Other	9	(16)
Postretirement benefit plan contributions	(13)	(17)
Changes in operating assets and liabilities, net of acquisitions:
Trade receivables	(229)	(526)
Inventories	69	(343)
Accounts payable	(32)	501
All other current assets and liabilities	254	275
Net cash provided by (used in) operating activities	1,400	1,180
Investing activities
Additions to properties	(506)	(350)
Issuance of notes receivable	(4)	0
Repayments of notes receivable	0	10
Purchases of available for sale securities	(15)	(15)
Sales of available for sale securities	15	14
Settlement of net investment hedges	29	37
Other	9	(8)
Net cash provided by (used in) investing activities	(472)	(312)
Financing activities
Net issuances (reductions) of notes payable	(115)	37
Issuances of long-term debt	896	0
Reductions of long-term debt	(227)	(33)
Net issuances of common stock	51	244
Common stock repurchases	(60)	(300)
Cash dividends	(610)	(596)
Other	(55)	(17)
Net cash provided by (used in) financing activities	(120)	(665)
Effect of exchange rate changes on cash and cash equivalents	(8)	(116)
Increase (decrease) in cash and cash equivalents	800	87
Cash and cash equivalents at beginning of period	299	286
Cash and cash equivalents at end of period	1,099	373
Supplemental cash flow disclosures of non-cash investing activities
Additions to properties included in accounts payable	$ 107	$ 75